The broad goal of this project is to define novel epigenetic mechanisms controlling Na+ homeostasis in mIMCD3 cells and in mouse kidney, with ENaC (epithelial sodium channel) as the model. The association of ENaC mutations with Liddle's syndrome and PHA-1 (pseudohypoaldosteronism type 1) as well as the tight and complex regulation of ENaC by aldosterone indicates the importance of ENaC in the regulation of Na+ balance and blood pressure. Aldosterone is a major regulator of Na+ absorption and acts primarily by controlling ENaC function at multiple levels, including transcription and cell surface expression. In the classical model, aldosterone enhances transcription by activating two distinct but similar types of NR (nuclear receptors): MR and GR (mineralocorticoid and glucocorticoid receptors). MR disruption in mouse leads to PHA-1 and animal death around day 10 after birth. Recently, we reported an alternative signaling pathway that couples aldosterone action to chromatin modifications and ENaC1 transcriptional activation through a series of events including reduction of histone H3 K79 methyltransferase Dot1a (disruptor of telomeric silencing 1) and putative transcription factor AF9 (ALL1-fused gene from chromosome 9), SGK1 (serum and glucocorticoid regulated kinase)-mediated phosphorylation of AF9 and thus downregulation of Dot1a-AF9 interaction, and targeted histone H3 K79 hypomethylation at the ENaC1 promoter in mIMCD3 cells. Despite these findings, the putative antagonism between the NR/aldosterone and Dot1a/AF9 complexes remains unaddressed;the correlation between aldosterone-stimulated ENaC transcription and ENaC activity is still not well defined;and the molecular defects derived from MR disruption that result in PHA-1 remain elusive. In this proposal, we intend to fill these gaps.
In Aim 1, we will test the hypothesis that the NR-aldosterone and Dot1a-AF9 complexes mutually inhibit the DNA binding activity of their opponent through MR-AF9 and/or GR-AF9 interactions to dynamically control ENaC1 transcription in mIMCD3 cells;
Aim 2 will test the hypothesis that changes in ENaC transcription translate into changes in ENaC activity in mIMCD3 cells;
and Aim 3 will examine MR-/- mice more fully to test the hypothesis that the components in our new aldosterone network and other ENaC regulatory factors are deregulated by MR deficiency, which contributes to the development of PHA-1, and to confirm the mutual antagonism of the two complexes on ENaC transcription and activity as defined in Aim 1 and 2. Therefore, the proposed studies will 1) integrate the two modes of aldosterone action: activation of NR and relief of Dot1a-AF9-mediated repression;2) link aldosterone action to chromatin-mediated ENaC transcriptional activation, enhanced ENaC activity and Na+ transport;and 3) shed new light on molecular mechanisms of PHA-1 development.

Public Health Relevance

Na+ balance is important for blood pressure control and is primarily achieved by the molecular action of the steroid hormone aldosterone on ENaC, an ion channel that transports Na+ through the cell membrane into the cells. The proposed studies are aimed to define novel mechanisms linking aldosterone action to chromatin modifications, transcriptional activation of ENaC, and enhanced Na+ uptake in mouse kidney, using one existing genetically engineered mouse model.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK080236-04
Application #
8247094
Study Section
Cellular and Molecular Biology of the Kidney Study Section (CMBK)
Program Officer
Rasooly, Rebekah S
Project Start
2009-03-01
Project End
2014-02-28
Budget Start
2012-03-01
Budget End
2013-02-28
Support Year
4
Fiscal Year
2012
Total Cost
$257,277
Indirect Cost
$85,759
Name
University of Texas Health Science Center Houston
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77225
Berrout, Jonathan; Mamenko, Mykola; Zaika, Oleg L et al. (2014) Emerging role of the calcium-activated, small conductance, SK3 K+ channel in distal tubule function: regulation by TRPV4. PLoS One 9:e95149
Li, Ju-Mei; Wu, Hongyu; Zhang, Wenzheng et al. (2014) The p97-UFD1L-NPL4 protein complex mediates cytokine-induced I*B* proteolysis. Mol Cell Biol 34:335-47
Zhang, Wenzheng; Yu, Zhiyuan; Wu, Hongyu et al. (2013) An Af9 cis-element directly targets Dot1a to mediate transcriptional repression of the ýýENaC gene. Am J Physiol Renal Physiol 304:F367-75
Zhang, Xi; Zhou, Qiaoling; Chen, Lihe et al. (2013) Mineralocorticoid receptor antagonizes Dot1a-Af9 complex to increase *ENaC transcription. Am J Physiol Renal Physiol 305:F1436-44
Wu, Hongyu; Chen, Lihe; Zhou, Qiaoling et al. (2013) Aqp2-expressing cells give rise to renal intercalated cells. J Am Soc Nephrol 24:243-52
Zhang, Weiru; Zhang, Yujin; Wang, Wei et al. (2013) Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension. Circ Res 112:1466-78
Wu, Hongyu; Chen, Lihe; Zhang, Xi et al. (2013) Aqp5 is a new transcriptional target of Dot1a and a regulator of Aqp2. PLoS One 8:e53342
Chen, Lihe; Wu, Hongyu; Pochynyuk, Oleh M et al. (2011) Af17 deficiency increases sodium excretion and decreases blood pressure. J Am Soc Nephrol 22:1076-86
Wu, Hongyu; Chen, Lihe; Zhou, Qiaoling et al. (2011) AF17 facilitates Dot1a nuclear export and upregulates ENaC-mediated Na+ transport in renal collecting duct cells. PLoS One 6:e27429
Zhang, Zhijing; Huang, Le; Reisenauer, Mary Rose et al. (2010) Widely expressed Af17 is likely not required for embryogenesis, hematopoiesis, and animal survival. Genesis 48:693-706

Showing the most recent 10 out of 13 publications